Insider Stock Trading History of Kapoor John N


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kapoor John N since year 2005. The trader's CIK number is 1033150. At the time of this reporting, Kapoor John N is the Director of Insys Therapeutics, Inc. . (stock ticker symbol INSY). See this page for all insider trading activities at Insys Therapeutics, Inc. .

Note that in the past KAPOOR JOHN N also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Kapoor John N since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-11 INSY Insys Therapeutics, Inc. Buy 17,500 8.93 156,345
2016-08-12 INSY Insys Therapeutics, Inc. Buy 5,700 18.57 105,854
2016-05-11 INSY Insys Therapeutics, Inc. Buy 40,000 12.94 517,720
2016-05-12 INSY Insys Therapeutics, Inc. Buy 10,000 12.41 124,120
2015-11-17 INSY Insys Therapeutics, Inc. Buy 5,000 29.77 148,875
2015-11-12 INSY Insys Therapeutics, Inc. Buy 10,000 26.35 263,500
2015-11-11 INSY Insys Therapeutics, Inc. Buy 10,000 25.80 258,050
2015-03-10 AKRX Akorn Inc Buy 19,000 44.26 840,940
2014-12-10 AKRX Akorn Inc Sale 17,700 41.22 729,594
2014-12-11 AKRX Akorn Inc Sale 32,300 41.17 1,329,791
2014-08-26 AKRX Akorn Inc Sale 50,000 38.99 1,949,500
2014-05-19 INSY Insys Therapeutics, Inc. Option Ex 15,991 11.37 181,817
2009-05-19 AKRX Akorn Inc Buy 37,500 .99 37,012
2009-05-18 AKRX Akorn Inc Buy 62,500 .91 57,062
2009-03-11 NEOL.PK Neopharm Inc Buy 22,000 .04 902
2009-03-12 NEOL.PK Neopharm Inc Buy 203,000 .06 12,180
2009-03-13 NEOL.PK Neopharm Inc Buy 25,000 .07 1,750
2008-06-05 NEOL Neopharm Inc Buy 11,500 .83 9,591
2008-06-03 NEOL Neopharm Inc Buy 20,000 .69 13,700
2008-06-04 NEOL Neopharm Inc Buy 25,000 .72 17,975
2008-05-30 NEOL Neopharm Inc Buy 9,600 .61 5,894
2008-06-02 NEOL Neopharm Inc Buy 28,500 .67 19,009
2008-05-28 NEOL Neopharm Inc Buy 30,000 .59 17,610
2008-05-29 NEOL Neopharm Inc Buy 400 .58 233
2008-03-20 AKN Akorn Inc Buy 40,000 4.67 186,880
2008-03-19 AKN Akorn Inc Buy 5,000 4.66 23,290
2008-03-14 AKN Akorn Inc Buy 5,000 4.51 22,550
2006-11-01 SCRX First Horizon Pharmaceutical Corp Sale 1,000,000 20.72 20,720,000
2006-10-16 NEOL Neopharm Inc Buy 5,000 7.94 39,680
2006-10-13 NEOL Neopharm Inc Buy 5,000 7.48 37,395
2006-10-12 NEOL Neopharm Inc Buy 5,000 7.20 36,020
2006-10-11 NEOL Neopharm Inc Buy 5,000 6.64 33,190
2006-10-10 NEOL Neopharm Inc Buy 5,000 6.81 34,050
2006-10-04 NEOL Neopharm Inc Buy 5,000 5.46 27,325
2006-10-05 NEOL Neopharm Inc Buy 10,000 5.58 55,820
2006-10-02 NEOL Neopharm Inc Buy 5,000 5.38 26,885
2006-10-03 NEOL Neopharm Inc Buy 5,000 5.57 27,845
2006-09-28 NEOL Neopharm Inc Buy 20,000 4.86 97,180
2006-09-21 NEOL Neopharm Inc Buy 20,000 5.00 99,900
2006-07-31 SCRX First Horizon Pharmaceutical Corp Sale 1,000,000 19.70 19,700,000
2006-05-16 FHRX First Horizon Pharmaceutical Corp Sale 1,000,000 23.55 23,550,000
2006-03-21 FHRX First Horizon Pharmaceutical Corp Sale 2,000,000 22.28 44,560,000
2006-03-17 AKN Akorn Inc Option Ex 500,000 2.25 1,125,000
2006-01-05 NEOL Neopharm Inc Buy 200,000 10.20 2,039,999
2005-08-23 OPTN Option Care Inc/de Sale 1,000,000 13.29 13,285,000
2005-05-24 OPTN Option Care Inc/de Sale 1,000,000 12.97 12,970,000
2005-03-14 NEOL Neopharm Inc Buy 68,500 8.13 556,905

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kapoor John N (Director of Insys Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.